DekaBank Deutsche Girozentrale lessened its holdings in shares of Bath & Body Works, Inc. (NYSE:BBWI – Get Rating) by 17.7% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 26,448 shares of the company's stock after selling 5,707 shares during the period. DekaBank Deutsche Girozentrale's holdings in Bath & Body Works were worth $879,000 at the end of the most recent reporting period.
Several other large investors also recently bought and sold shares of BBWI. PGGM Investments acquired a new position in Bath & Body Works in the 3rd quarter valued at about $1,175,000. Park Avenue Securities LLC boosted its holdings in Bath & Body Works by 7.8% in the 3rd quarter. Park Avenue Securities LLC now owns 12,723 shares of the company's stock valued at $415,000 after purchasing an additional 926 shares during the last quarter. U.S. Capital Wealth Advisors LLC acquired a new position in Bath & Body Works in the 3rd quarter valued at about $259,000. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. boosted its holdings in Bath & Body Works by 9.3% in the 3rd quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 147,887 shares of the company's stock valued at $4,821,000 after purchasing an additional 12,627 shares during the last quarter. Finally, SG Americas Securities LLC lifted its holdings in shares of Bath & Body Works by 193.8% in the 3rd quarter. SG Americas Securities LLC now owns 22,426 shares of the company's stock worth $731,000 after acquiring an additional 14,793 shares during the last quarter. Hedge funds and other institutional investors own 96.34% of the company's stock.
Get
Bath & Body Works alerts:
Wall Street Analyst Weigh In
Several equities analysts have recently commented on the stock. Bank of America upped their price objective on shares of Bath & Body Works from $48.00 to $50.00 in a report on Thursday, November 17th. Barclays decreased their price objective on shares of Bath & Body Works to $39.00 in a report on Monday, November 21st. JPMorgan Chase & Co. upped their price objective on shares of Bath & Body Works from $40.00 to $43.00 in a report on Tuesday, January 3rd. Morgan Stanley upped their price objective on shares of Bath & Body Works from $72.00 to $76.00 and gave the stock an "overweight" rating in a report on Thursday, November 17th. Finally, Robert W. Baird increased their target price on shares of Bath & Body Works from $48.00 to $50.00 and gave the stock an "outperform" rating in a report on Thursday, November 17th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, Bath & Body Works currently has an average rating of "Moderate Buy" and a consensus target price of $51.52.
Bath & Body Works Price Performance
Shares of NYSE:BBWI opened at $45.16 on Friday. The stock has a market cap of $10.32 billion, a P/E ratio of 11.76, a P/E/G ratio of 0.99 and a beta of 1.67. The firm has a fifty day moving average price of $43.00 and a 200 day moving average price of $37.88. Bath & Body Works, Inc. has a 1-year low of $25.75 and a 1-year high of $62.26.
Bath & Body Works (NYSE:BBWI – Get Rating) last issued its quarterly earnings results on Wednesday, November 16th. The company reported $0.40 earnings per share for the quarter, topping analysts' consensus estimates of $0.19 by $0.21. The firm had revenue of $1.60 billion during the quarter, compared to analysts' expectations of $1.56 billion. Bath & Body Works had a net margin of 12.48% and a negative return on equity of 40.90%. Sell-side analysts expect that Bath & Body Works, Inc. will post 3.15 EPS for the current fiscal year.
Bath & Body Works Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Friday, December 2nd. Stockholders of record on Friday, November 18th were paid a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 1.77%. The ex-dividend date of this dividend was Thursday, November 17th. Bath & Body Works's dividend payout ratio (DPR) is presently 20.83%.
Bath & Body Works Profile
(Get Rating)
Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
Read More
- Get a free copy of the StockNews.com research report on Bath & Body Works (BBWI)
- EVs, Robotics Among Growth Drivers As Chipmaker STMicro Gaps Up
- Does Oil Services Firm NOV Have Enough Energy To Maintain Rally?
- Shopify Clears Cup-With-Handle Base: Can Momentum Continue?
- Chevron Delights Shareholders with $75 Billion in Share Buybacks
- The Future Of E-Commerce: Analysis And New Data
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.
